Omicron BA.2.86 cross-neutralising activity in community sera from the UK
Open Access
- 9 November 2023
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 402 (10417) , 2075-2076
Abstract
No abstract availableKeywords
Funding Information
- Meningitis Research Foundation
- UK Research and Innovation
- Medical Research Council (MC_UU_00034/6)
- Wellcome Trust
- British Society for Antimicrobial Chemotherapy
This publication has 2 references indexed in Scilit:
- Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86The Lancet Infectious Diseases, 2023
- Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccinationPLOS Pathogens, 2021